季度财报
Checkpoint(CKPT)05-11 04:25
$Checkpoint(CKPT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000738 Act: 34 Size: 5 MB 网页链接
简介:Checkpoint Therapeutics, Inc.于2014年11月10日在特拉华州注册成立。Checkpoint是一家临床阶段免疫疗法和靶向肿瘤学公司,专注于实体瘤癌症患者新疗法的收购、开发和商业化。该公司正在评估先导抗体候选产品cosibelimab,这是一种从Dana-Farber癌症研究所获得许可的抗程序性死亡配体1抗体,正在进行一项全球、开放标签、多队列1期临床试验,用于选定的复发或转移性癌症的检查点治疗初治患者,包括旨在支持一项或多项上市批准申请的局部晚期和转移性皮肤鳞状细胞癌正在进行的队列。
今开:2.6 | 昨收:2.63 |
最高:2.65 | 最低:2.47 |
涨停价: | 跌停价: |
总市值:94629493 |
Checkpoint(CKPT)05-11 04:25
$Checkpoint(CKPT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-24-000738 Act: 34 Size: 5 MB 网页链接
Checkpoint(CKPT)05-17 07:35
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-062664 Size: 6 KB 网页链接
Checkpoint(CKPT)05-17 07:35
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-062663 Size: 6 KB 网页链接
Checkpoint(CKPT)05-14 19:35
$Checkpoint(CKPT)$ 8-K Current report, items 5.02, 5.03, 5.07, and 9.01 Accession Number: 0001104659-24-060882 Act: 34 Size: 439 KB 网页链接
Checkpoint(CKPT)07-03 20:45
$Checkpoint(CKPT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-077591 Act: 33 Size: 322 KB 网页链接
Checkpoint(CKPT)07-03 20:45
$Checkpoint(CKPT)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-24-077593 Act: 34 Size: 996 KB 网页链接
Checkpoint(CKPT)05-18 05:15
$Checkpoint(CKPT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-063092 Act: 34 Size: 50 KB 网页链接
Checkpoint(CKPT)06-24 19:55
$Checkpoint(CKPT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-074148 Act: 34 Size: 225 KB 网页链接
Checkpoint(CKPT)05-25 04:15
$Checkpoint(CKPT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-065120 Act: 33 Size: 96 KB 网页链接
Checkpoint(CKPT)05-17 07:45
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-062666 Size: 5 KB 网页链接
美股律师郝俊波04-08 13:24
$Checkpoint(CKPT)$ 【Checkpoint Therapeutics(CKPT)最新证券集体诉讼】
Checkpoint Therapeutics Inc(CKPT)因证券欺诈案已经于近日被投资者集体诉讼至法院。在目前的诉讼中投资者指控该公司及部分高管在本案诉讼期间进行虚假陈述,违反证券法令投资者受损。投资者向法院申请判令被告赔偿因...查看全文
SeekingBiotech2023-01-07 20:24
近期,美股Checkpoint Therapeutics宣布向FDA递交 Cosibelimab 用于不适合接受治愈性手术或放射治疗的转移性皮肤鳞状细胞癌(CSCC)或局部晚期CSCC的生物制品许可申请(BLA)。
Cosibelimab是一款完全人源化、具高度亲和力的PD-L1单克隆抗体。$Checkpoint医疗(CKPT)$查看全文
美股滚雪球2022-10-05 09:53
$LogicBio医疗(LOGC被六倍溢价收购,$Harpoon Therapeutics(HARP)$ 、$Checkpoint医疗(CKPT)$ 、$ProQR Therapeutics(PRQR)$ 谁会是下一个?查看全文
chuminhua2022-06-17 10:53
6月16日,Checkpoint Therapeutics 表示, 在研抗 PD-L1 抗体cosibelimab 在局部晚期皮肤鳞状细胞癌( cSCC )患者的注册试验中取得了积极的中期结果。该公司已经计划向 FDA 提交申请用于转移性 cSCC 治疗。
Checkpoint 表示,截至 3 月数据截止,31 名不适合进行根治性手术或放疗的局部晚期 c...查看全文
chuminhua2022-01-26 12:22
1月25日,Checkpoint Therapeutics $Checkpoint医疗(CKPT)$ 报告,其抗 PD-L1 抗体 cosibelimab 达到了晚期癌症患者 I 期试验的主要终点,表明皮肤鳞状细胞癌 (cSCC) 队列的客观缓解率 (ORR) 接近 50% .该公司表示,计划在今年晚些时候向 FDA 提交申请,首席执行官 James Oliviero 表示:“一旦获...查看全文
令狐不冲9992021-11-03 20:58
11.3盘前异动:$Checkpoint医疗(CKPT)$ $Big 5体育用品(BGFV)$ $Senseonics控股(SENS)$查看全文
明天还是一样的天空2020-09-19 01:54
冷枪手假亦真2020-09-11 21:57
$Checkpoint医疗(CKPT)$ 一路狂奔🐎🏃♀️🏃🏃♀️查看全文
冷枪手假亦真2020-07-20 22:43
冷枪手假亦真2020-07-17 22:30
$Checkpoint(CKPT)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-24-078936 Act: 33 Size: 12 KB 网页链接
$Checkpoint(CKPT)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-24-077593 Act: 34 Size: 996 KB 网页链接
$Checkpoint(CKPT)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-077591 Act: 33 Size: 322 KB 网页链接
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-076441 Size: 5 KB 网页链接
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-076442 Size: 7 KB 网页链接
$Checkpoint(CKPT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-074148 Act: 34 Size: 225 KB 网页链接
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-065215 Size: 4 KB 网页链接
$Checkpoint(CKPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-065214 Size: 5 KB 网页链接
$Checkpoint(CKPT)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-24-065121 Size: 5 KB 网页链接
$Checkpoint(CKPT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-065120 Act: 33 Size: 96 KB 网页链接